- Home
- EXPE vs ZBH Comparison
EXPE vs ZBH Comparison
Compare EXPE & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXPE
- ZBH
- Stock Information
- Founded
- EXPE 1996
- ZBH 1927
- Country
- EXPE United States
- ZBH United States
- Employees
- EXPE N/A
- ZBH N/A
- Industry
- EXPE Transportation Services
- ZBH Industrial Specialties
- Sector
- EXPE Consumer Discretionary
- ZBH Health Care
- Exchange
- EXPE Nasdaq
- ZBH Nasdaq
- Market Cap
- EXPE 22.6B
- ZBH 19.1B
- IPO Year
- EXPE 1999
- ZBH N/A
- Fundamental
- Price
- EXPE $207.44
- ZBH $102.81
- Analyst Decision
- EXPE Buy
- ZBH Hold
- Analyst Count
- EXPE 26
- ZBH 20
- Target Price
- EXPE $201.13
- ZBH $112.39
- AVG Volume (30 Days)
- EXPE 2.1M
- ZBH 1.8M
- Earning Date
- EXPE 08-07-2025
- ZBH 08-07-2025
- Dividend Yield
- EXPE 0.77%
- ZBH 0.93%
- EPS Growth
- EXPE 45.71
- ZBH N/A
- EPS
- EXPE 8.24
- ZBH 4.11
- Revenue
- EXPE $14,018,000,000.00
- ZBH $7,833,800,000.00
- Revenue This Year
- EXPE $5.62
- ZBH $7.64
- Revenue Next Year
- EXPE $6.29
- ZBH $5.64
- P/E Ratio
- EXPE $25.17
- ZBH $25.01
- Revenue Growth
- EXPE 5.69
- ZBH 4.11
- 52 Week Low
- EXPE $126.46
- ZBH $89.22
- 52 Week High
- EXPE $213.00
- ZBH $116.71
- Technical
- Relative Strength Index (RSI)
- EXPE 70.26
- ZBH 67.08
- Support Level
- EXPE $181.58
- ZBH $101.56
- Resistance Level
- EXPE $210.83
- ZBH $103.57
- Average True Range (ATR)
- EXPE 6.74
- ZBH 2.30
- MACD
- EXPE 2.17
- ZBH 0.97
- Stochastic Oscillator
- EXPE 85.73
- ZBH 94.63
About EXPE Expedia Group Inc.
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2024 sales), air tickets (3%), rental cars, cruises, in-destination, and other (10%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.